Changchun BCHT Biotechnology Co. (SHA:688276)
China · Delayed Price · Currency is CNY 18.59
-0.30 (-1.59%)
Mar 19, 2026, 3:00 PM CST
SHA:688276 Revenue
In the year 2025, Changchun BCHT Biotechnology Co. had annual revenue of 591.81M CNY, down -51.85%. Changchun BCHT Biotechnology Co. had revenue of 117.37M in the quarter ending December 31, 2025, a decrease of -42.20%.
Revenue
591.81M
Revenue Growth
-51.85%
P/S Ratio
12.99
Revenue / Employee
464.53K
Employees
1,266
Market Cap
7.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 591.81M | -637.27M | -51.85% |
| Dec 31, 2024 | 1.23B | -595.60M | -32.64% |
| Dec 31, 2023 | 1.82B | 753.24M | 70.30% |
| Dec 31, 2022 | 1.07B | -130.58M | -10.86% |
| Dec 31, 2021 | 1.20B | -239.33M | -16.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 6.85B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Cisen Pharmaceutical | 3.56B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Shandong Wit Dyne Health | 2.36B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 1.94B |